Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 12 January 2026

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

Figure Technology Solutions shares fell 9.6% to $52.50 Monday after releasing preliminary Q4 metrics. The company reported $2.705 billion in Q4 consumer loan marketplace volume, up 131% from a year earlier, and $328 million in $YLDS stablecoin circulation. Investors are watching for Tuesday’s U.S. CPI report and the Fed’s January meeting for rate signals.
12 January 2026
··
Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

Bread Financial shares fell 10.8% to $71.65 Monday after Donald Trump proposed a one-year 10% cap on credit card interest rates, with no details on enforcement. The selloff spread to other lenders, including Synchrony and Capital One. Analysts questioned the proposal’s viability, citing legal hurdles. Bread Financial reports earnings Jan. 29, with investors watching for commentary on policy risks.
12 January 2026
·····
Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

Lululemon shares rose 3.2% to $210.43 Monday after the company said holiday-quarter revenue and profit would reach the high end of its forecast, citing strong seasonal demand. The retailer maintained its margin and expense outlook. CEO Calvin McDonald steps down Jan. 31, with interim co-CEOs named as the board searches for a replacement. Founder Chip Wilson has launched a proxy fight as Elliott Management builds a $1 billion stake.
12 January 2026
··
GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next

GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next

GeneDx shares fell about 14% to $115.75 Monday after releasing preliminary 2025 results and 2026 revenue guidance above analyst estimates. The company projected 2026 revenue of $540–$555 million and positive adjusted net income. Investors are awaiting CEO remarks at the Jan. 14 J.P. Morgan Healthcare Conference and the Feb. 23 earnings report for further details. The latest figures remain unaudited and subject to revision.
12 January 2026
·
Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

Honeywell shares edged up 0.1% to $207.50 after launching new software tools for retail and warehouse operations. Citi lowered its price target to $262 but maintained a buy rating. Investors await Honeywell’s Jan. 29 results and 2026 outlook for signs of demand and margin trends. Honeywell will start rolling out its new Smart Shopping Platform in February.
12 January 2026
··
D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton shares rose about 1% to $158.82 Monday afternoon, tracking gains in other major homebuilders. Keefe Bruyette & Woods cut its price target on the stock to $168 from $175 but kept a “Market Perform” rating. Investors are focused on D.R. Horton’s Jan. 20 earnings after the company warned that affordability pressures could keep sales incentives high in 2026.
12 January 2026
·····
SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

SoFi Technologies shares fell 2.4% to $26.74 Monday after CEO Anthony Noto said Trump’s proposed 10% cap on credit-card rates could boost demand for personal loans. The stock had reached $28.05 before reversing. Capital One and Synchrony dropped 7.5% and 8.9%, while Visa and Mastercard each lost about 2%. Trump’s plan would cap rates for one year starting January 20.
12 January 2026
··
Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

Nike shares fell 0.6% to $65.52 Monday afternoon, underperforming the broader market despite Jefferies reaffirming its buy rating and $110 price target ahead of the ICR conference. Nike’s latest quarter showed revenue up 1% to $12.4 billion, but net income dropped 32% and gross margin fell to 40.6% due to higher tariffs. Wholesale revenue rose, while direct and Converse sales declined.
12 January 2026
··
Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

Lemonade shares jumped 7.7% to $85.81 Monday, hitting a new 52-week high amid heavy short interest and volatile trading. About 20% of the float was shorted as of mid-December, raising the risk of sharp moves. Chief insurance officer John Peters sold 10,000 shares Jan. 6 at $80 under a pre-set plan. The next earnings report is expected Feb. 24.
12 January 2026
··
Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

Abercrombie & Fitch shares fell 17.3% to $103.26 after the company cut its full-year sales growth forecast and lowered its holiday-quarter outlook. The retailer now expects fiscal 2025 net sales growth of at least 6%, down from a prior 6%–7% range, and factored in $90 million in tariff expenses. Investors are watching the ICR Conference this week for further updates on demand and pricing.
12 January 2026
·
Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

Merck shares fell 1.1% to $109.27 Monday amid speculation over a possible $28–32 billion acquisition of Revolution Medicines, though no deal has been finalized. The SPDR S&P Biotech ETF dropped 2.1%. Analysts estimate Revolution’s RAS inhibitor drugs could generate over $10 billion in sales by 2035. Merck also faces a potential $2 billion annual revenue hit after U.S. vaccine schedule changes affecting Gardasil and RotaTeq.
12 January 2026
··
Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

Goldman Sachs shares rose 0.6% to $944.73 in Monday afternoon trading ahead of fourth-quarter earnings due Jan. 15. Markets weighed Trump’s proposed 10% cap on credit-card interest rates and threats to indict Fed Chair Jerome Powell. Traders are focused on Tuesday’s U.S. CPI report and major bank earnings. Goldman’s chief economist now expects Fed rate cuts in June and September.
12 January 2026
···
Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.
12 January 2026
····
Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard stock drops as Trump’s 10% credit-card rate cap plan rattles card-linked names

Mastercard shares fell 1.7% to $565.93 Monday after President Trump called for a one-year 10% cap on credit card interest rates, sending card stocks lower. Visa dropped 1.7% and American Express slid 4.2%. Analysts said such a cap would need Congressional approval and warned it could hurt lender profits. Separately, Google named Mastercard as an endorser of its new Universal Commerce Protocol for AI-driven shopping.
12 January 2026
·
Reddit stock (RDDT) slips as insider selling hits the tape; CPI report is the next test

Reddit stock (RDDT) slips as insider selling hits the tape; CPI report is the next test

Reddit shares fell 1.1% to $241.85 Monday as the S&P 500 and Nasdaq-100 ETFs edged up 0.2%. Wells Fargo raised its price target to $207 but kept an equal-weight rating. SEC filings showed Reddit’s chief legal officer and CFO sold shares under preset trading plans. Daily active users rose 19% to 116 million, with revenue up 68% to $585 million.
12 January 2026
········
First Majestic Silver stock jumps 7% as silver rips to a fresh record — what investors watch next

First Majestic Silver stock jumps 7% as silver rips to a fresh record — what investors watch next

First Majestic Silver shares jumped 7% to $20.24 Monday as silver surged 6.8% to $85.39 an ounce, drawing heavy trading volume. Peer miners also rallied, with Hecla Mining up nearly 9%. Investors await Tuesday’s U.S. inflation data, which could shift rate and metals forecasts. JPMorgan and other banks have delayed expectations for Fed rate cuts into 2026 or later.
12 January 2026
·
1 … 368 369 370 371 372 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
New York, Feb 7, 2026, 11:29 ET — Market closed. AbbVie shares closed up 2% on Friday at $223.43, extending a second straight session of gains as U.S. stocks rallied. The stock is still roughly 9% below its 52-week high, and trading volume ran a bit under its recent average. (MarketWatch) The bounce comes as investors work through AbbVie’s post-earnings reset and what it means for 2026. The drugmaker said fourth-quarter net revenues rose 10% to $16.618 billion and adjusted profit per share—excluding certain items—was $2.71; it forecast 2026 adjusted earnings of $14.37 to $14.57 a share. Chief Executive Robert
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop